ZeClinics Therapeutics is a biopharmaceutical company focused on the development of treatments for cardiovascular diseases. Nowadays cardiovascular diseases are the cause of death of at least a third of the global population. Despite this issue, there is not enough research on this area because all the focus is on fighting cancer. ZeClinics proposes a revolutionary…
Inveniam advised TedCas in a seed round with Business Angels and Private Investors.
TedCas is a leading healthcare technology provider that revolutionises access and handing of medical information.
Stroke is a devastating life event that often results in permanent disability, in particular, reduced motor control capability or, in severe cases, a complete absence of muscular function. Almost 1 million people suffer a stroke in Europe every year, with 20% of these suffering from drop foot, which significantly reduces their ability to walk. However,…
A few weeks ago, The New Yorker published the article “Are we already living in virtual reality?” by Joshua Rothman. In the article, Joshua describes the journey of Thomas Metzinger to recreate his out-of-body experiences, which lead him to fund Virtual BodyWorks. Next to that, Joshua states his own experiences with virtual reality in many…